Susan Bergin, the General Counsel of Juvenescence, is a dual-qualified Solicitor and Medicinal Chemist with extensive experience in life sciences including contentious and non-contentious intellectual property, commercial law, and corporate transactions.

After leaving Trinity College Dublin, where she studied Medicinal Chemistry, she worked in Nigeria, Nepal, the United States, and Canada. Susan also holds an LLM from the University of Law, a Master of Science degree in Intellectual Property Law, and a Post-Graduate Diploma in Intellectual Property Law and Practice from the University of Oxford.

Prior to joining Juvenescence, Susan was an Associate at Jones Day and Marks&Clerk Law in London where she worked on high stakes patent litigation and major corporate transactions for major pharmaceutical clients including AbbVie, AstraZeneca, Celgene, Genentech, and Pfizer.

Susan is also an executive board member in the group’s Irish companies and plays a key part developing and optimizing the corporate operations across the group. 

Susan stays active through biohacking, breathwork, meditation, yoga, cold plunges, and grounding in nature as often as possible.